Total Payments
$11,395
2024 Payments
$2,100
Companies
43
Transactions
628
Medicare Patients
1,165
Medicare Billing
$93,299
Payment Breakdown by Category
Food & Beverage$10,763 (94.5%)
Education$547.61 (4.8%)
Travel$84.25 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,763 | 617 | 94.5% |
| Education | $547.61 | 10 | 4.8% |
| Travel and Lodging | $84.25 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,866 | 132 | $0 (2024) |
| ABBVIE INC. | $1,665 | 93 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,027 | 47 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $640.51 | 33 | $0 (2024) |
| PFIZER INC. | $529.04 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $516.36 | 23 | $0 (2024) |
| MAYNE PHARMA INC. | $513.24 | 46 | $0 (2022) |
| Lilly USA, LLC | $366.15 | 20 | $0 (2024) |
| Almirall LLC | $351.60 | 11 | $0 (2024) |
| Aqua Pharmaceuticals | $277.99 | 15 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,100 | 114 | Janssen Biotech, Inc. ($452.40) |
| 2023 | $1,992 | 89 | Janssen Biotech, Inc. ($486.40) |
| 2022 | $1,640 | 115 | Janssen Biotech, Inc. ($373.95) |
| 2021 | $1,005 | 51 | Janssen Biotech, Inc. ($218.30) |
| 2020 | $755.80 | 40 | Janssen Biotech, Inc. ($205.62) |
| 2019 | $1,003 | 55 | Galderma Laboratories, L.P. ($243.53) |
| 2018 | $1,217 | 78 | Galderma Laboratories, L.P. ($207.97) |
| 2017 | $1,682 | 86 | Aqua Pharmaceuticals ($277.99) |
All Payment Transactions
628 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $106.05 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: Immunology | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: Immunology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.73 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.89 | General |
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 247 | 429 | $59,940 | $19,160 |
| 2022 | 6 | 293 | 661 | $85,598 | $28,724 |
| 2021 | 8 | 333 | 613 | $79,801 | $26,582 |
| 2020 | 8 | 292 | 421 | $61,662 | $18,833 |
Total Patients
1,165
Total Services
2,124
Medicare Billing
$93,299
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 68 | $17,700 | $5,673 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 74 | $13,635 | $4,700 | 34.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 36 | 46 | $11,002 | $3,587 | 32.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 34 | $7,268 | $2,210 | 30.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 43 | 59 | $8,248 | $2,203 | 26.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 27 | 148 | $2,087 | $787.64 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 100 | $26,270 | $8,981 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 94 | $17,490 | $6,212 | 35.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 47 | 70 | $16,888 | $6,203 | 36.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 53 | 89 | $12,535 | $3,385 | 27.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 36 | 39 | $8,515 | $2,476 | 29.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 35 | 269 | $3,901 | $1,466 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 67 | $17,752 | $6,141 | 34.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 44 | 53 | $12,775 | $4,926 | 38.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 72 | $13,469 | $4,710 | 35.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 46 | 49 | $10,844 | $3,204 | 29.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 59 | 84 | $11,622 | $3,142 | 27.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $6,151 | $1,888 | 30.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 45 | 254 | $3,526 | $1,353 | 38.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $3,662 | $1,218 | 33.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 40 | 57 | $13,317 | $4,748 | 35.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 53 | $11,778 | $3,829 | 32.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 41 | 45 | $9,405 | $2,619 | 27.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 52 | $7,972 | $2,519 | 31.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 29 | 29 | $6,369 | $1,716 | 26.9% |
About Dr. Tatiana Sousa, M.D
Dr. Tatiana Sousa, M.D is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1427292937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tatiana Sousa, M.D has received a total of $11,395 in payments from pharmaceutical and medical device companies, with $2,100 received in 2024. These payments were reported across 628 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,763).
As a Medicare-enrolled provider, Sousa has provided services to 1,165 Medicare beneficiaries, totaling 2,124 services with total Medicare billing of $93,299. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 04/28/2009
- Last Updated 02/06/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1427292937
Products in Payments
- TREMFYA (Drug) $1,546
- DUPIXENT (Biological) $491.95
- SKYRIZI (Biological) $478.56
- EUCRISA (Drug) $438.05
- DORYX (Drug) $431.63
- TALTZ (Drug) $366.15
- Humira (Biological) $313.16
- RINVOQ (Biological) $312.83
- REMICADE (Biological) $307.15
- Winlevi (Drug) $281.10
- EPIDUO FORTE (Drug) $267.77
- OPZELURA (Drug) $261.76
- Otezla (Drug) $236.32
- ORACEA (Drug) $217.41
- AMELUZ (Drug) $215.62
- Klisyri (Drug) $206.11
- Veltin (Drug) $186.34
- Finacea (Drug) $171.08
- ENSTILAR (Drug) $162.82
- BOTOX (Biological) $152.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608
Dermatology $231,608